WBR0368: Difference between revisions

Jump to navigation Jump to search
(Created page with "{{WBRQuestion |QuestionAuthor=Mahmoud Sakr M.D. |ExamType=USMLE Step 1 |MainCategory=Genetics |SubCategory=Musculoskeletal/Rheumatology |MainCategory=Genetics |SubCategory=Mus...")
 
m (refreshing WBR questions)
 
(3 intermediate revisions by one other user not shown)
Line 1: Line 1:
{{WBRQuestion
{{WBRQuestion
|QuestionAuthor=Mahmoud Sakr M.D.
|QuestionAuthor=Mahmoud Sakr M.D. (Reviewed by  {{SSK}})
|ExamType=USMLE Step 1
|ExamType=USMLE Step 1
|MainCategory=Genetics
|MainCategory=Genetics
|SubCategory=Musculoskeletal/Rheumatology
|SubCategory=Neurology
|MainCategory=Genetics
|MainCategory=Genetics
|SubCategory=Musculoskeletal/Rheumatology
|SubCategory=Neurology
|MainCategory=Genetics
|MainCategory=Genetics
|SubCategory=Musculoskeletal/Rheumatology
|SubCategory=Neurology
|MainCategory=Genetics
|MainCategory=Genetics
|MainCategory=Genetics
|MainCategory=Genetics
|SubCategory=Musculoskeletal/Rheumatology
|MainCategory=Genetics
|MainCategory=Genetics
|SubCategory=Musculoskeletal/Rheumatology
|SubCategory=Neurology
|MainCategory=Genetics
|MainCategory=Genetics
|SubCategory=Musculoskeletal/Rheumatology
|SubCategory=Neurology
|MainCategory=Genetics
|MainCategory=Genetics
|SubCategory=Musculoskeletal/Rheumatology
|SubCategory=Neurology
|MainCategory=Genetics
|MainCategory=Genetics
|SubCategory=Neurology
|MainCategory=Genetics
|MainCategory=Genetics
|SubCategory=Musculoskeletal/Rheumatology
|MainCategory=Genetics
|Prompt=17 year-old-boy presents to your office with a chief complaint of foot drop as well as loss of touch sensation in the feet, ankles and legs. His symptoms have been progressive over the past several years. On exam, he has wasting of muscle tissue of the lower parts of the legs with an "inverted bottle" appearance. You also notice high arched feet or pes cavus. He tells you he has several family members with a similar condition. Disorders in which of the following genes are likely responsible for this inherited disease?
|SubCategory=Neurology
|Explanation=Charcot–Marie–Tooth disease (CMT) is caused by mutations that cause defects in neuronal proteins. Loss of touch sensation in the feet, ankles and legs, as well as in the hands, wrists and arms is characteristic in various types of the disease. Sensory and proprioceptive nerves in the hands and feet are often damaged, while pain nerves are left intact. Wasting of muscle tissue of the lower parts of the legs may give rise to a "stork leg" or "inverted bottle" appearance.  
|Prompt=A 20-year-old man presents to the neurology clinic for left foot weakness and gradual loss sensation in the both lower extremities. His symptoms have been progressive over the past 2 years. On physical examination, the physician notes significant pes cavus with left foot drop, lower extremity weakness and muscle wasting giving the legs an inverted champagne bottle appearance. The patient explains that several of his family members have had the same condition. A mutation in which of the following gene is likely to be responsible for this patient's condition?
|AnswerA=CMT gene
|Explanation=Charcot–Marie–Tooth (CMT) disease is a common inherited disorder occurring in approximately 1 in 2500 people in the United States. CMT is caused by mutations in ''CMT'' genes involved in the structure and function of either the peripheral nerve axon or the myelin sheath. This leads to slowly progressive degeneration of peripheral motor and sensory nerves. Patients with CMT typically present in late childhood or early adulthood with sensorimotor neuropathy. Loss of touch sensation in the feet, ankles and legs, as well as in the hands, wrists and arms is characteristic in various types of the disease. Sensory and proprioceptive nerves in the hands and feet are often damaged, while pain nerves are left intact. Wasting of muscle tissue of the lower parts of the legs may give rise to a "stork leg" or "inverted champagne bottle" appearance.
 
|AnswerA=''CMT'' gene
 
|AnswerAExp=Charcot–Marie–Tooth (CMT) disease is caused by mutations in one of several ''CMT'' genes involved in the structure and function of either the peripheral nerve axon or the myelin sheath.
|AnswerAExp=Correct!
|AnswerB=''FXN'' gene
Charcot–Marie–Tooth disease (CMT) is caused by mutations that cause defects in neuronal proteins. Loss of touch sensation in the feet, ankles and legs, as well as in the hands, wrists and arms is characteristic in various types of the disease.  Sensory and proprioceptive nerves in the hands and feet are often damaged, while pain nerves are left intact. Wasting of muscle tissue of the lower parts of the legs may give rise to a "stork leg" or "inverted bottle" appearance.  
|AnswerBExp=Friedreich's ataxia (FRDA) is caused by ''FXN'' gene mutation that results in reduced expression of frataxin protein.
|AnswerB=FXN gene
 
|AnswerBExp=FXN gene associated reduced expression of frataxin protein is the cause of Friedreich's ataxia (FRDA).
|AnswerC=DUX4 gene
|AnswerC=DUX4 gene
 
|AnswerCExp=Facioscapulohumeral muscular dystrophy is caused by ''DUX4'' gene mutation.
|AnswerCExp=DUX4 gene associated facioscapulohumeral muscular dystrophy (FSHD) initially affects the muscles of the face, shoulders, and upper arms with progressive weakness.  
|AnswerD=''Dystrophin'' gene
|AnswerD=Dystrophin gene
|AnswerDExp=Duchenne muscular dystrophy (DMD) is caused by ''Dystrophin'' gene frameshift mutation.
 
|AnswerE=''DYSF'' gene
|AnswerDExp=Dystrophin gene disorder is responsible for Duchenne muscular dystrophy (DMD), which is the most common childhood form of muscular dystrophy; it generally affects only boys (with extremely rare exceptions), becoming clinically evident when a child begins walking. By age 10, the child may need braces for walking and by age 12, most patients are confined to a wheelchair
|AnswerEExp=Distal muscular dystrophy is caused by a mutation in the ''DYSF''. The disease is characterized by relatively late-onset of symptoms (20-60 years of age), which include weakness and wasting of muscles of the hands, forearms, and lower legs. It is usually progressive but not life-threatening.
|AnswerE=DYSF gene
|EducationalObjectives=Charcot–Marie–Tooth (CMT) disease is caused by mutations in ''CMT'' genes involved in the structure and function of either the peripheral nerve axon or the myelin sheath.
|AnswerEExp=DYSF gene relates to distal muscular dystrophies; age at onset: 20 to 60 years; symptoms include weakness and wasting of muscles of the hands, forearms, and lower legs; progress is slow and not life-threatening.
|References=Bird TD. Charcot-Marie-Tooth Neuropathy Type 1. 1998 Aug 31 [Updated 2015 Mar 26]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2015. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1205/ <br>
First Aid 2015 page 489.
|RightAnswer=A
|RightAnswer=A
|WBRKeyword=Charcot-Marie-Tooth, CMT, Neuropathy, Mutation
|Approved=Yes
|Approved=Yes
}}
}}

Latest revision as of 00:19, 28 October 2020

 
Author [[PageAuthor::Mahmoud Sakr M.D. (Reviewed by Serge Korjian M.D.)]]
Exam Type ExamType::USMLE Step 1
Main Category MainCategory::Genetics
Sub Category SubCategory::Neurology
Prompt [[Prompt::A 20-year-old man presents to the neurology clinic for left foot weakness and gradual loss sensation in the both lower extremities. His symptoms have been progressive over the past 2 years. On physical examination, the physician notes significant pes cavus with left foot drop, lower extremity weakness and muscle wasting giving the legs an inverted champagne bottle appearance. The patient explains that several of his family members have had the same condition. A mutation in which of the following gene is likely to be responsible for this patient's condition?]]
Answer A AnswerA::''CMT'' gene
Answer A Explanation AnswerAExp::Charcot–Marie–Tooth (CMT) disease is caused by mutations in one of several ''CMT'' genes involved in the structure and function of either the peripheral nerve axon or the myelin sheath.
Answer B AnswerB::''FXN'' gene
Answer B Explanation AnswerBExp::Friedreich's ataxia (FRDA) is caused by ''FXN'' gene mutation that results in reduced expression of frataxin protein.
Answer C AnswerC::DUX4 gene
Answer C Explanation AnswerCExp::Facioscapulohumeral muscular dystrophy is caused by ''DUX4'' gene mutation.
Answer D AnswerD::''Dystrophin'' gene
Answer D Explanation AnswerDExp::Duchenne muscular dystrophy (DMD) is caused by ''Dystrophin'' gene frameshift mutation.
Answer E AnswerE::''DYSF'' gene
Answer E Explanation [[AnswerEExp::Distal muscular dystrophy is caused by a mutation in the DYSF. The disease is characterized by relatively late-onset of symptoms (20-60 years of age), which include weakness and wasting of muscles of the hands, forearms, and lower legs. It is usually progressive but not life-threatening.]]
Right Answer RightAnswer::A
Explanation [[Explanation::Charcot–Marie–Tooth (CMT) disease is a common inherited disorder occurring in approximately 1 in 2500 people in the United States. CMT is caused by mutations in CMT genes involved in the structure and function of either the peripheral nerve axon or the myelin sheath. This leads to slowly progressive degeneration of peripheral motor and sensory nerves. Patients with CMT typically present in late childhood or early adulthood with sensorimotor neuropathy. Loss of touch sensation in the feet, ankles and legs, as well as in the hands, wrists and arms is characteristic in various types of the disease. Sensory and proprioceptive nerves in the hands and feet are often damaged, while pain nerves are left intact. Wasting of muscle tissue of the lower parts of the legs may give rise to a "stork leg" or "inverted champagne bottle" appearance.

Educational Objective: Charcot–Marie–Tooth (CMT) disease is caused by mutations in CMT genes involved in the structure and function of either the peripheral nerve axon or the myelin sheath.
References: Bird TD. Charcot-Marie-Tooth Neuropathy Type 1. 1998 Aug 31 [Updated 2015 Mar 26]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2015. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1205/
First Aid 2015 page 489.]]

Approved Approved::Yes
Keyword WBRKeyword::Charcot-Marie-Tooth, WBRKeyword::CMT, WBRKeyword::Neuropathy, WBRKeyword::Mutation
Linked Question Linked::
Order in Linked Questions LinkedOrder::